WHAT IS THE NEXT TECH PATHWAY PROGRAM?
Those who purchased a MiniMedTM 670G system after 11/7/19 were automatically entered into the Next Tech Pathway program. This program allows your patients to access the MiniMedTM 770G system for $0. The order must be shipped no later than 9/1/21. See program terms and conditions for full details.
HOW CAN YOUR PATIENTS REDEEM THEIR NEW TECHNOLOGY?
Instruct your patients to:
Or your patient may also call 877-585-0208. Specialists are available from 8AM-6PM CT.
UPGRADE PROGRAMS FOR YOUR PATIENTS
If your patients are not enrolled in Next Tech Pathway, we have other programs available for those using an in-warranty pump. Learn more.
FREQUENTLY ASKED QUESTIONS
See below for questions your patients may ask regarding the Next Tech Pathway program.
During your patients' warranty period, with more than 6 months left, your patient will have a one-time opportunity to upgrade to the MiniMedTM 770G system for $0. See below for more details. Terms & Conditions apply.
To redeem a Next Tech Pathway, intruct your patients to sign-in to their Account. Under Devices and products, select the “Check upgrade eligibility” button. They may also redeem by calling us at 877-585-0208. Specialists are available from 8AM-6PM CT. The total out-of-pocket cost to purchase the MiniMed™ 770G system using the Next Tech Pathway is $0.
The Next Tech Pathway program is a one-time in-warranty upgrade to the MiniMedTM 770G system. Order must be shipped no later than 9/1/21.
No, warranty dates do not reset. The warranty date of an upgraded insulin pump will remain the same as the warranty date of the initial pump purchased.
The $0 price will be honored if your patient complies with program terms. If they do not return their old insulin pump within 90 days, they will be charged $3,200.
Refers to SmartGuardTM Auto Mode. Some user interaction required.
The Next Tech Pathway program (the “Program”) allows eligible, enrolled participants whose MiniMed™ 670G system order is shipped starting on 11/7/19 to be included. The last day to place an order is 12/1/20. This Program allows for an upgrade to our next MiniMed™ system at $0. Eligibility dates subject to change.
To be eligible for the Program, participants must purchase a MiniMed™ 670G system and meet one of the following requirements:
This program is not available to customers on a rental program such as those enrolled in federal, state, or other government-funded healthcare program like Medicare, Medicare Advantage, Medicaid, Medigap, the Department of Defense (“DoD”) or TRICARE.
To upgrade through the Program, all participants must agree and are subject to these terms and conditions:
Important Safety Information: MiniMedTM 770G System with SmartGuardTM Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.
The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library